Amarin Corp Plc (AMRN)

[ziploc_1]

QUOTE from SA article..."With several large M&A deals involving biotechs being acquired so far in 2023, RBC Capital Markets says such activity could be on the rise ahead.
Given recent M&A activity, we "remind investors that there remains M&A appetite among large pharmas, and to continue to propel the small/mid-cap biotech space off of its recent lows."

I agree that a Eurocetric BP could benefit from buying Amarin, especially at these ridiculously low prices.